Oct 08, 2021 17:31 Source: BSE
SMS Pharmaceuticals - Statement Of Investor Complaints For The Quarter Ended September 2021
| No.of Investor complaints pending at the beginning of the quarter || No.of Investor complaints received during the quarter|| No.of Investor complaints disposed of during the quarter || No.of Investor complaints unresolved at the end of the quarter |
| Name of the Signatory || :- ||V S Venkatish|
|Designation || :- ||Company Secretary and Compliance Officer|
Oct 08, 2021 16:56 Source: BSE
SMS Pharmaceuticals - Shareholding for the Period Ended September 30, 2021
SMS Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here
Oct 06, 2021 10:25 Source: BSE
SMS Pharmaceuticals - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that the share certificates as per details given below are reported to have been lost / misplaced and request from shareholder is received by the Company through its Registrar and Share Transfer Agent M/s Aarthi consultants Private Limited for issue of duplicate share certificate(s) in lieu thereof.
Oct 04, 2021 10:30 Source: BSE
SMS Pharmaceuticals - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
SMS Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
Oct 01, 2021 18:43 Source: BSE
SMS Pharmaceuticals - Voting Results Of 33Rd AGM Under Regulation 44(3) Of SEBI (LODR) Regulations
Ref: Outcome Of E-Voting And Scrutinizers Report Dated 30Th September, 2021
The 33rd Annual General Meeting (AGM) of the Company was held on 30th September, 2021 at 09.00 A.M. at the Registered Office of the Company Situated at Plot.No: 72, H.No: 8-2-334/3&4, Road No.5, Opp. SBI Executive Enclave, Banjara Hills, Hyderabad 500034. 1. In accordance with the Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, with reference to all the items of the business contained in the AGM Notice dated 8th September, 2021 were transacted and approved by the members with requisite majority. 2. Report of the Scrutinizer dated 30th September, 2021, pursuant to Section 108 of the Companies Act, 2013 and Rule 20(4)(xii) of the Companies (Management and Administration) Rules, 2015 is annexed.
Sep 28, 2021 10:14 Source: BSE
SMS Pharmaceuticals - Closure of Trading Window
This is to inform you that the Trading Window for dealing in securities of the Company by Directors, Promoters, Designated Employees and Specified Connected Persons of the Company and associated of the Company shall remain closed with effect from 1st October, 2021 till 48 hours after the declaration of unaudited financial results for the quarter and half year ended September 30th, 2021, in terms of the Code of Conduct of the Company.